STALICLA signs agreement with Novartis on neurodevelopmental disorders
STALICLA SA, a clinical-stage biotech company advancing the first precision neurobiology platform for patients with…
January 9, 2023 - 2 minutes
STALICLA SA, a clinical-stage biotech company advancing the first precision neurobiology platform for patients with…